Value of a facilitated quality improvement initiative on cardiovascular disease risk: findings from an evaluation of the Aggressively Treating Global Cardiometabolic Risk Factors to Reduce Cardiovascular Events (AT GOAL)
Supporting Files
-
10 2015 ; 10-2015
-
Available in CDC Stacks on 2018-10-10T00:00:00Z
File Language:
English
Details
-
Alternative Title:J Eval Clin Pract
-
Personal Author:
-
Description:Rationale, aims and objectives ; In the United States, cardiovascular disease (CVD) is the leading cause of death. The US Centers for Disease Control and Prevention contracted an evaluation of the Aggressively Treating Global Cardiometabolic Risk Factors to Reduce Cardiovascular Events (AT GOAL) programme as part of its effort to identify strategies to address CVD risk factors. ; Methods ; This study analysed patient-level data from 7527 patients in 43 primary care practices. The researchers assessed average change in control rates for CVD-related measures across practices, and then across patients between baseline and a patient’s last visit during the practice’s tenure in the programme (referred to as ‘end line’) using repeated measures analysis of variance and random effects generalized least squares, respectively. ; Results ; Among non-diabetic patients, there were significant increases in control rates for overall blood pressure (74.3% to 78.0%, P = 0.0002), systolic blood pressure (70.3% to 80.6%, P = 0.0099), diastolic blood pressure (90.1% to 92.7%, P = 0.0001) and low-density lipoprotein (LDL; 48.6% to 53.1%, P = 0.0001) between baseline and end line. Among diabetic patients, there was a significant increase in diastolic blood pressure control (59.8% to 61.9%, P = 0.0141). While continuous CVD-related outcomes show an overall trend between baseline and end line, patients with uncontrolled measures at baseline showed a decrease between baseline and end line relative to their counterparts who were controlled at baseline. ; Conclusions ; Findings from the AT GOAL evaluation support the value of a facilitated quality improvement (QI) initiative on managing CVD risk.
-
Subjects:
- Adolescent
- Adult
- Black or African American
- Aged
- Aged, 80 and over
- Benchmarking
- Blood Pressure
- Body Mass Index
- Cardiovascular Diseases
- Cholesterol, LDL
- Diabetes Mellitus
- Education, Medical, Continuing
- Glycated Hemoglobin
- Humans
- Insurance Coverage
- Insurance, Health
- Middle Aged
- Primary Health Care
- Primary Prevention
- Quality Improvement
- Risk Factors
- United States
- White People
- Young Adult
-
Keywords:
-
Source:J Eval Clin Pract. 21(5):963-970
-
Pubmed ID:26223497
-
Pubmed Central ID:PMC6178234
-
Document Type:
-
Funding:
-
Volume:21
-
Issue:5
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:20d4e30668f7245dbceb000730c8d907bed7ce42fb82daebbe800d8f3cdca02e
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access